Harvard Bioscience (HBIO) announce the expansion of its distribution agreement with Fisher Scientific, a part of Thermo Fisher Scientific (TMO). Under this new agreement, Fisher Scientific will now offer Harvard Bioscience pumps, spectrophotometers, and BTX electroporation systems in the United States, complementing the existing distribution agreement in Europe. This agreement provides Harvard Bioscience access to hundreds of Fisher Scientific sales representatives who will now offer customers both established product lines-such as pumps and electroporation systems-and access to emerging technologies, including the Mesh MEA for advanced organoid research.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HBIO:
- Harvard Bioscience price target lowered to $2 from $3 at Benchmark
- Resilient Performance and Strategic Growth Drive Buy Rating for Harvard Bioscience Amid Market Challenges
- Harvard Bioscience Appoints Stephen DeNelsky to Board
- Harvard Bioscience appoints DeNelsky to board of directors
- Harvard Bioscience Offers CFO $100K Retention Bonus